OLD Category: FFPE

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

• Keam SP, Halse H, Nguyen T...Haupt Y, Williams SG, Neeson PJ

Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study

• Chen X, Fan Z, Li KKW...Shi Z, Yu J, Zhou L

Correlation of Novel ALKATI with ALK Immunohistochemistry and Clinical Outcomes in Metastatic Melanoma

• Shah KK, Neff JL, Erickson LA...Copland JA, Halling KC, Flotte TJ

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

• Marks DK, Gartrell RD, El Asmar M...Connolly E, Saenger Y, Kalinsky K

Resolving Metabolic Heterogeneity in Experimental Models of the Tumor Microenvironment from a Stable Isotope Resolved Metabolomics Perspective

• Fan TW-M, Higashi RM, Chernayavskaya Y, Lane AN

Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma

• Low SYY, Bte Syed Sulaiman N, Tan EEK...Looi WS, Low DCY, Seow WT

Gene expression profiling of gray zone lymphoma

• Sarkozy C, Chong L, Takata K, Chavez EA, Miyata-Takata T, Duns G, Telenius A, Boyle M, Slack GW, Laurent C, Farinha P, Molina TJ, Copie-Bergman C, Damotte D, Salles GA, Mottok A, Savage KJ, Scott DW, Traverse-Glehen A, Steidl C.

Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo

• Boukhedouni N, Martins C, Darrigade AS...Bernard FX, Seneschal J, Boniface K

Immune Landscapes Predict Chemotherapy Resistance and Immunotherapy Response in Acute Myeloid Leukemia

• Vadakekolathu J, Minden MD, Hood T, Church SE, Reeder S, Altmann H, Sullivan AH, Viboch EJ, Patel T, Ibrahimova N, Warren SE, Arruda A, Liang Y, Smith TH, Foulds GA, Bailey MD, Gowen-MacDonald J, Muth J, Schmitz M, Cesano A, Pockley AG, Valk PJM, Löwenberg B, Bornhäuser M, Tasian SK, Rettig MP, Davidson-Moncada JK, DiPersio JF, Rutella S

Prognostic gene expression signature for high-grade serous ovarian cancer

• Millstein J, Budden T, Goode EL, Doherty JA, Pharoah PDP, Ramus SJ

Digital spatial profiling application in breast cancer: a user’s perspective

• McCart Reed AE, Bennett J, Kutasovic JR, Yeong J, Simpson PT, Lakhani SR

Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer

• Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, Munro SA, Tiegs L, McCarthy JB, Nelson AC, Schwertfeger KL.